Morgan Stanley’s Medifast MED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.31M | Sell |
325,312
-9,546
| -3% | -$103K | ﹤0.01% | 4410 |
|
|
2025
Q4 | $3.58M | Sell |
334,858
-253,681
| -43% | -$3.04M | ﹤0.01% | 4428 |
|
|
2025
Q3 | $8.05M | Buy |
588,539
+130,753
| +29% | +$1.83M | ﹤0.01% | 3737 |
|
|
2025
Q2 | $6.43M | Buy |
457,786
+164,225
| +56% | +$2.16M | ﹤0.01% | 3841 |
|
|
2025
Q1 | $3.96M | Buy |
293,561
+7,555
| +3% | +$113K | ﹤0.01% | 4124 |
|
|
2024
Q4 | $5.04M | Sell |
286,006
-35,001
| -11% | -$650K | ﹤0.01% | 3992 |
|
|
2024
Q3 | $6.14M | Sell |
321,007
-15,753
| -5% | -$304K | ﹤0.01% | 3811 |
|
|
2024
Q2 | $7.35M | Sell |
336,760
-87,940
| -21% | -$2.34M | ﹤0.01% | 3575 |
|
|
2024
Q1 | $16.3M | Sell |
424,700
-112,802
| -21% | -$5.46M | ﹤0.01% | 2918 |
|
|
2023
Q4 | $36.1M | Buy |
537,502
+316,628
| +143% | +$22.1M | ﹤0.01% | 2791 |
|
|
2023
Q3 | $16.5M | Sell |
220,874
-132,571
| -38% | -$11.8M | ﹤0.01% | 2652 |
|
|
2023
Q2 | $32.6M | Sell |
353,445
-8,885
| -2% | -$791K | ﹤0.01% | 1979 |
|
|
2023
Q1 | $37.6M | Buy |
362,330
+71,523
| +25% | +$7.93M | ﹤0.01% | 1820 |
|
|
2022
Q4 | $33.5M | Buy |
290,807
+5,826
| +2% | +$678K | ﹤0.01% | 1854 |
|
|
2022
Q3 | $30.9M | Buy |
284,981
+132,834
| +87% | +$19M | ﹤0.01% | 1744 |
|
|
2022
Q2 | $27.5M | Buy |
152,147
+76,560
| +101% | +$13.7M | ﹤0.01% | 1937 |
|
|
2022
Q1 | $12.9M | Sell |
75,587
-9,609
| -11% | -$1.81M | ﹤0.01% | 2598 |
|
|
2021
Q4 | $17.8M | Sell |
85,196
-1,371
| -2% | -$283K | ﹤0.01% | 2283 |
|
|
2021
Q3 | $16.7M | Sell |
86,567
-65,453
| -43% | -$16.1M | ﹤0.01% | 2280 |
|
|
2021
Q2 | $43M | Buy |
152,020
+20,606
| +16% | +$5.58M | 0.01% | 1431 |
|
|
2021
Q1 | $27.8M | Sell |
131,414
-7,865
| -6% | -$1.88M | ﹤0.01% | 1623 |
|
|
2020
Q4 | $27.3M | Buy |
139,279
+78,494
| +129% | +$13.9M | ﹤0.01% | 1536 |
|
|
2020
Q3 | $10M | Sell |
60,785
-63,728
| -51% | -$10.5M | ﹤0.01% | 2030 |
|
|
2020
Q2 | $17.3M | Buy |
124,513
+74,716
| +150% | +$6.86M | ﹤0.01% | 1524 |
|
|
2020
Q1 | $3.11M | Sell |
49,797
-33,519
| -40% | -$3.05M | ﹤0.01% | 2931 |
|
|
2019
Q4 | $9.13M | Sell |
83,316
-1,828
| -2% | -$177K | ﹤0.01% | 2522 |
|
|
2019
Q3 | $8.82M | Buy |
85,144
+1,988
| +2% | +$214K | ﹤0.01% | 2258 |
|
|
2019
Q2 | $10.7M | Buy |
83,156
+16,453
| +25% | +$2.29M | ﹤0.01% | 2088 |
|
|
2019
Q1 | $8.51M | Sell |
66,703
-95,807
| -59% | -$12.2M | ﹤0.01% | 2186 |
|
|
2018
Q4 | $20.3M | Buy |
162,510
+91,258
| +128% | +$15.6M | 0.01% | 1446 |
|
|
2018
Q3 | $15.8M | Buy |
71,252
+13,677
| +24% | +$2.77M | ﹤0.01% | 1908 |
|
|
2018
Q2 | $9.22M | Sell |
57,575
-69,976
| -55% | -$8.95M | ﹤0.01% | 2469 |
|
|
2018
Q1 | $11.9M | Buy |
127,551
+50,899
| +66% | +$3.8M | ﹤0.01% | 2167 |
|
|
2017
Q4 | $5.35M | Buy |
76,652
+2,315
| +3% | +$154K | ﹤0.01% | 3047 |
|
|
2017
Q3 | $4.41M | Sell |
74,337
-37,331
| -33% | -$1.86M | ﹤0.01% | 3093 |
|
|
2017
Q2 | $4.63M | Buy |
111,668
+12,812
| +13% | +$557K | ﹤0.01% | 2923 |
|
|
2017
Q1 | $4.39M | Sell |
98,856
-3,260
| -3% | -$140K | ﹤0.01% | 2984 |
|
|
2016
Q4 | $4.25M | Buy |
102,116
+29,159
| +40% | +$1.17M | ﹤0.01% | 3169 |
|
|
2016
Q3 | $2.76M | Sell |
72,957
-75,478
| -51% | -$2.71M | ﹤0.01% | 3218 |
|
|
2016
Q2 | $4.94M | Sell |
148,435
-16,466
| -10% | -$531K | ﹤0.01% | 2618 |
|
|
2016
Q1 | $4.98M | Sell |
164,901
-108,841
| -40% | -$3.18M | ﹤0.01% | 2541 |
|
|
2015
Q4 | $8.32M | Sell |
273,742
-21,284
| -7% | -$634K | ﹤0.01% | 2162 |
|
|
2015
Q3 | $7.92M | Buy |
295,026
+134,487
| +84% | +$3.92M | ﹤0.01% | 2205 |
|
|
2015
Q2 | $5.19M | Buy |
160,539
+50,350
| +46% | +$1.6M | ﹤0.01% | 2763 |
|
|
2015
Q1 | $3.3M | Buy |
110,189
+37,465
| +52% | +$1.19M | ﹤0.01% | 3134 |
|
|
2014
Q4 | $2.44M | Buy |
72,724
+55,769
| +329% | +$1.74M | ﹤0.01% | 3386 |
|
|
2014
Q3 | $556K | Sell |
16,955
-57,340
| -77% | -$1.76M | ﹤0.01% | 4498 |
|
|
2014
Q2 | $2.26M | Sell |
74,295
-26,403
| -26% | -$823K | ﹤0.01% | 3390 |
|
|
2014
Q1 | $2.93M | Buy |
100,698
+43,101
| +75% | +$1.15M | ﹤0.01% | 3097 |
|
|
2013
Q4 | $1.5M | Buy |
57,597
+11,257
| +24% | +$288K | ﹤0.01% | 3602 |
|
|
2013
Q3 | $1.25M | Sell |
46,340
-49,955
| -52% | -$1.34M | ﹤0.01% | 3604 |
|
|
2013
Q2 | $2.48M | Buy |
+96,295
| New | +$2.53M | ﹤0.01% | 2987 |
|
Other funds holding MED
SCP
VCM
Morgan Stanley's MED Position: Q1 2026 in Review
Morgan Stanley reduced its Medifast (MED) stake by 2.9% in Q1 2026, selling an estimated $103K and leaving 325,312 shares worth $3.31M. The position accounts for ﹤0.01% of the portfolio, ranked #4410.
Morgan Stanley first reported a position in MED in Q2 2013 and has held it in 52 quarters since. The position peaked at $43M in Q2 2021. 111 funds tracked by Wall St. Rank hold MED as of Q1 2026.
- Morgan Stanley held 325,312 shares of Medifast worth $3.31M as of Q1 2026.
- Morgan Stanley sold 9,546 Medifast shares in Q1 2026, an estimated $103K.
- Medifast made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #4410 holding.
- Morgan Stanley first reported a position in Medifast in Q2 2013 and has held it in 52 quarters since.
- Morgan Stanley's Medifast position peaked at $43M in Q2 2021.
- 111 funds tracked by Wall St. Rank held Medifast as of Q1 2026.
Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.